Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT03896685
Previous Study | Return to List | Next Study

Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q) (endTB-Q)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03896685
Recruitment Status : Recruiting
First Posted : April 1, 2019
Last Update Posted : September 4, 2020
Sponsor:
Collaborators:
Partners in Health
Harvard Medical School
Epicentre
Institute of Tropical Medicine, Belgium
Socios En Salud, Peru
Interactive Research and Development
Information provided by (Responsible Party):
Médecins Sans Frontières, France

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 2022
Estimated Study Completion Date : December 2022